Close Menu

NEW YORK (GenomeWeb) – Apis Assay Technologies, a company supported by Qiagen and Health Innovation Manchester in the UK, has officially launched with the goal of expediting the commercialization of biomarkers into new diagnostic tests.

According to its website, Apis' business model has three main areas of focus: a biomarker industrial research program; so-called "fast-tracking" of biomarkers and diagnostic platforms for commercialization; and contract development.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The chief executive of the National Health Service in England is to call for tumor-agnostic drugs to be "fast-tracked," according to the Times.

Researchers in Australia are sequencing the Wollemi pine tree to try to protect it from extinction, Australia's ABC News reports.

Computerworld ranks Illumina as one of the top midsize organizations to work at in IT.

In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.